| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.4 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.4 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |